Xwell (XWEL) Cash from Operations Growth (3y) (2013 - 2026)
Xwell (XWEL) Cash from Operations Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 11.33% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -9.46% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 20.12% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -11.38% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 11.55% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 35.64% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 24.17% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 5.18% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.37% |
| 10 | Xwell | 7.47 Mn | -9.34 Mn | 2.35 Mn | 7.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.77% |
| Dec 31, 2025 | 81.64% |
| Sep 30, 2025 | 37.88% |
| Jun 30, 2025 | 29.61% |
| Mar 31, 2025 | -33.05% |
| Dec 31, 2024 | -33.94% |
| Sep 30, 2024 | -34.61% |
| Jun 30, 2024 | -31.29% |
| Mar 31, 2024 | -1.72% |
| Dec 31, 2023 | 26.57% |
| Sep 30, 2023 | 6.51% |
| Jun 30, 2023 | 30.50% |
| Mar 31, 2023 | -18.59% |
| Dec 31, 2022 | -129.81% |
| Sep 30, 2022 | -104.63% |
| Jun 30, 2022 | -387.72% |
| Mar 31, 2022 | -126.64% |
| Dec 31, 2021 | 65.08% |
| Sep 30, 2021 | 112.30% |
| Jun 30, 2021 | 49.33% |